c-Met inhibition is required for the celecoxib-attenuated stemness property of human colorectal cancer cells.
Lin, Yueh-Ming
c-Met inhibition is required for the celecoxib-attenuated stemness property of human colorectal cancer cells. [electronic resource] - Journal of cellular physiology 07 2019 - 10336-10344 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-4652
10.1002/jcp.27701 doi
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Celecoxib--pharmacology
Cell Line, Tumor
Colorectal Neoplasms--drug therapy
Cyclooxygenase 2--metabolism
Cyclooxygenase 2 Inhibitors--pharmacology
Humans
Neoplastic Stem Cells--drug effects
Proto-Oncogene Proteins c-met--antagonists & inhibitors
c-Met inhibition is required for the celecoxib-attenuated stemness property of human colorectal cancer cells. [electronic resource] - Journal of cellular physiology 07 2019 - 10336-10344 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-4652
10.1002/jcp.27701 doi
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Celecoxib--pharmacology
Cell Line, Tumor
Colorectal Neoplasms--drug therapy
Cyclooxygenase 2--metabolism
Cyclooxygenase 2 Inhibitors--pharmacology
Humans
Neoplastic Stem Cells--drug effects
Proto-Oncogene Proteins c-met--antagonists & inhibitors